SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-21-000249
Filing Date
2021-01-25
Accepted
2021-01-25 17:15:31
Documents
5
Period of Report
2021-01-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K phio_8k.htm 8-K 28250
2 FORM OF COMMON STOCK WARRANT phio_ex0401.htm EX-4.1 116759
3 FORM OF PRE-FUNDED WARRANT phio_ex0402.htm EX-4.2 111826
4 FORM OF SECURITIES PURCHASE AGREEMENT phio_ex1001.htm EX-10.1 256540
5 FORM OF REGISTRATION RIGHTS AGREEMENT phio_ex1002.htm EX-10.2 103294
  Complete submission text file 0001683168-21-000249.txt   617969
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 21550738
SIC: 2834 Pharmaceutical Preparations